This article was originally published on Opto – Understand What Really Moves Markets.
It’s been a long and choppy path for VMUK’s share price since then, but the stock climbed to 153.60p on 18 November ahead of full-year earnings, before falling away as the results failed to lift investors’ confidence.
Despite the ongoing uncertainty caused by a second wave of COVID-19, the vaccines’ rollout does offer hope of better times ahead. A slow return to normality should help VMUK, which includes the Clydesdale Bank, Yorkshire Bank and Virgin Money brands, in its quest for profitability.
So, while analysts are eyeing an upturn for the bank later this year, is VMUK’s share price really undervalued?
Could move to profitability boost VMUK’s share price?
Following the bank’s full-year results on 26 November, which saw profit-before-tax tumble 77% to £124m – and a statutory loss-after-tax of £141m – broker Morgan Stanley trimmed its target for VMUK’s share price from 150p to 145p. This downgrade also came just a day after VMUK announced it had set aside £501m for bad debts owing to the COVID-19 pandemic.
However, despite those gloomy figures, there may be light at the end of the tunnel for VMUK’s share price, report Simply Wall St, with the bank “bordering on break-even” according to analysts covering the stock. VMUK is predicted to have posted a final annual loss in 2020, before going on to make a profit of £75m this year, with its FY2021 results due to be published on 24 November. Simply Wall St calculates that VMUK must grow by an “extremely buoyant” average annual growth rate of 70% to break even within 12 months.
Should the group’s actual profits fall short of estimates, which is certainly plausible in the current economic environment, investors are still likely to gain confidence in VMUK’s share price in the longer term if the bank can move the dial in the right direction, starting with next month’s Q1 trading update.
Metrics point to potential share price gains
VMUK’s share price is significantly undervalued compared to its fair value and price relative to the market, according to Simply Wall St. They reckon the current fair value for VMUK is 179.00p, which, based on Monday’s close at 136.25p, makes the shares undervalued by 31.37%.
Morningstar’s quantitative equity research paints a similar picture – they calculate that VMUK’s fair value estimate is 166.00p, 22.8% up on 20 January’s closing price.
Further underlining VMUK’s share price prospects, the stock is currently the biggest mover of 10 component stocks in RRG Momentum, a signature share basket which tracks strong relative momentum in UK stocks, created by trading professionals Julius De Kempenaer and Trevor Neil.
The Essential Stock Market Digest: Join 50,000+ Opto subscribers getting market-moving news direct to their inbox, 4 x a week.
MyWallSt operates a full disclosure policy. MyWallSt staff currently hold long positions in companies mentioned above. Read our full disclosure policy here.
Leveraged ETFs are complex financial instruments that carry significant risks. Certain leveraged ETFs are only considered appropriate for experienced traders.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.
Guest Author at MyWallSt
The investment universe is changing beyond all recognition, and with a thematic focus, investors can capitalise on this wholesale disruption. From Genomics to Artificial Intelligence, disruptive innovation empowers companies to displace industry incumbents, and secure majority market share. Opto exists to identify those businesses, and help investors to invest in the next big idea.